Cyclerion Therapeutics (CYCN) Depreciation & Amortization (CF) (2018 - 2022)

Cyclerion Therapeutics' Depreciation & Amortization (CF) history runs 5 years deep, the most recent figure standing at $100000.0 for Q3 2022.

• In Q3 2022, Depreciation & Amortization (CF) fell 83.33% year-over-year to $100000.0; the TTM figure through Jun 2023 stood at $100000.0 (down 87.44% YoY), while the FY2022 annual figure was $65000.0, down 86.23% from the prior year.
• Depreciation & Amortization (CF) was $100000.0 for Q3 2022 at Cyclerion Therapeutics, roughly flat from $100000.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $800000.0 in Q2 2019 to a low of $48000.0 in Q4 2021.
• Historically, Depreciation & Amortization (CF) has averaged $413157.9 across 5 years, with a median of $466000.0 in 2018.
• The sharpest annual moves came in 2019 and 2021: Depreciation & Amortization (CF) surged 100.0% in 2019, then sank 89.79% in 2021.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $466000.0 in 2018, then soared by 40.13% to $653000.0 in 2019, then decreased by 28.02% to $470000.0 in 2020, then tumbled by 89.79% to $48000.0 in 2021, then surged by 108.33% to $100000.0 in 2022.
• The last three Depreciation & Amortization (CF) figures came in at $100000.0 (Q3 2022), $100000.0 (Q2 2022), and $48000.0 (Q1 2022), per Business Quant data.